Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter
email:    

Investor News

Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings

Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions
Start-Ups

IPO News
IPO


Clinical - Phase II
Ablynx (ABLYF) Opens Recruitment For First-In-Infant Phase 2a Study With Its Anti-Rsv Nanobody, ALX-0171 12/17/2014 7:23:45 AM
Stemline Therapeutics, Inc. (STML) Initiates SL-401 Clinical Trial In Four Rare Myeloproliferative Neoplasms 12/17/2014 7:29:19 AM
RXi Pharmaceuticals (RXII) Announces Sustained Effect Of RXI-109 At Three Months Post Scar Revision Surgery And The Completion Of Enrollment For Its Phase 2a Trial RXI-109-1301 12/17/2014 8:02:58 AM
Pfizer (PFE) Initiates Phase 2 Study Of PF-06252616 In Duchenne Muscular Dystrophy 12/17/2014 8:16:27 AM
Pivotal Therapeutics Inc. Release: VASCAZEN POMEGA Phase 2a Trial Protocol Cleared Clinical Evaluation By French FDA 12/17/2014 8:49:35 AM
Velocity Pharmaceutical Development And Tigercat Pharma, Inc. Announce Phase 2 Results For VPD-737 In Patients With Chronic Pruritus 12/17/2014 8:54:21 AM
First Patient Treated In Mapi Pharma's Phase 2a Clinical Trial Of GA Depot For Relapsing Remitting Multiple Sclerosis (RRMS) 12/17/2014 9:19:07 AM
Poxel Announces Positive Top Line Results For Its Antidiabetic Agent Imeglimin In A Phase 2b Dose-Ranging Trial 12/17/2014 11:22:31 AM
Neovacs SA Announces Top Line Phase 2b Clinical Trial Results Of TNF-Kinoid In Rheumatoid Arthritis And Update On Clinical Programs 12/16/2014 7:32:16 AM
Anavex Life Sciences Corp. (AVXL.OB) Begins Enrollment Of Alzheimer's Patients In Phase 2a Clinical Trial Of ANAVEX 2-73 And ANAVEX PLUS 12/16/2014 7:45:42 AM
Galapagos NV (GLPG.BR) Regains Full Rights To GPR84 Inhibitor GLPG1205 12/16/2014 9:27:31 AM
GENFIT Corp. (ALGFT): Gft505 Treatment Prevents Evolution To Cirrhosis 12/16/2014 9:35:14 AM
SOV Therapeutics Announces Successful Phase 2b Study Of Oral Testosterone Undecanoate For Treatment Of Primary And Secondary Hypogonadism In Adult Males 12/16/2014 8:27:26 AM
Isis Pharmaceuticals, Inc. (ISIS) Initiates Phase 1/2 Study Of ISIS-DMPK Rx In Patients With Myotonic Dystrophy Type 1 12/16/2014 8:08:48 AM
OncoGenex Pharmaceuticals Inc. (OGXI) Announces Completion Of Patient Enrollment In The Rainier™ Clinical Trial Evaluating Apatorsen In Combination With ABRAXANEв Plus Gemcitabine In Patients With Metastatic Pancreatic Cancer 12/16/2014 9:57:49 AM
1234567
//-->